P796 Effectiveness and safety of ustekinumab for patients with ulcerative colitis: A single-centre retrospective study

• Published in: Journal of Crohn's and colitis Vol. 17; no. Supplement_1; pp. i927 - i928
• Main Authors: Kimura, M, Shimizu, M, Shirai, M, Sakaguchi, Y, Kobayashi, K, Iruya, R, Seki, S, Naitou, D, Nishimiya, T, Oouchi, Y, Shibamoto, M, Iwashita, H, Miyamura, M, Kikuchi, H, Yamada, A, Nakamura, K, Matsuoka, K
• Format: Journal Article
• Language: English
• Published: 30.01.2023

Abstract Background Ustekinumab, a monoclonal antibody directed against the interleukin 12/23 p40 subunit, was approved worldwide in 2020 for the treatment of ulcerative colitis. The efficacy of ustekinumab in inducing and maintaining remission in moderate to severe ulcerative colitis was demonstrat...